-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PSEtIFQsWySD7YBw+EdLyBtd1Jr/SNUpFIzwtGS8Es+AneQ7a6rq0XU+3EIB/LdG vXpKgDMel9s7U95FTld0Ew== 0001085146-08-001576.txt : 20081112 0001085146-08-001576.hdr.sgml : 20081111 20081112164047 ACCESSION NUMBER: 0001085146-08-001576 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080930 FILED AS OF DATE: 20081112 DATE AS OF CHANGE: 20081112 EFFECTIVENESS DATE: 20081112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ORACLE INVESTMENT MANAGEMENT INC CENTRAL INDEX KEY: 0001012622 IRS NUMBER: 133709517 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05592 FILM NUMBER: 081181367 BUSINESS ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2126886262 MAIL ADDRESS: STREET 1: 200 GREENWICH AVE STREET 2: 3RD FL CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 orac3q08.txt ORACLE INVESTMENT MANAGEMENT INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2008 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Oracle Investment Management, Inc. Address: 200 Greenwich Avenue Greenwich, CT 06830 13F File Number: 28-05592 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Larry Feinberg Title: President Phone: (203) 862-7900 Signature, Place, and Date of Signing: /s/ Mark Merritt Greenwich, CT November 12, 2008 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form13F Information Table Entry Total: 30 Form13F Information Table Value Total: $869,363,321 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- ACORDA THERAPEUTICS INC COM 00484M106 15576387 653098 SH SOLE 653098 0 0 ALEXION PHARMACEUTICALS INC COM 015351109 21982455 559350 SH SOLE 559350 0 0 ALLERGAN INC COM 018490102 26388034 512389 SH SOLE 512389 0 0 ANTIGENICS INC DEL COM 037032109 478410 302791 SH SOLE 302791 0 0 AUXILIUM PHARMACEUTICALS INC COM 05334D107 255960 7900 SH SOLE 7900 0 0 BIOGEN IDEC INC COM 09062X103 30892191 614281 SH SOLE 614281 0 0 CELGENE CORP COM 151020104 28975089 457887 SH SOLE 457887 0 0 CEPHALON INC COM 156708109 48259455 622783 SH SOLE 622783 0 0 ELAN PLC ADR 284131208 54522228 5109862 SH SOLE 5109862 0 0 EXPRESS SCRIPTS INC COM 302182100 762708 10332 SH SOLE 10332 0 0 GENENTECH INC COM NEW 368710406195695565 2206761 SH SOLE 2206761 0 0 GILEAD SCIENCES INC COM 375558103 15924870 316300 SH SOLE 316300 0 0 GTX INC DEL COM 40052B108 64282522 3379733 SH SOLE 3379733 0 0 HLTH CORPORATION COM 40422Y101 65522978 5732544 SH SOLE 5732544 0 0 INTERMUNE INC COM 45884X103 8493404 496400 SH SOLE 496400 0 0 MANNKIND CORP COM 56400P201 6508282 1751364 SH SOLE 1751364 0 0 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 10620587 712313 SH SOLE 712313 0 0 MIDDLEBROOK PHARMACEUTICAL I COM 596087106 3487497 2324998 SH SOLE 2324998 0 0 OMNICARE INC COM 681904108 14513947 504482 SH SOLE 504482 0 0 ONYX PHARMACEUTICALS INC COM 683399109 45129485 1247360 SH SOLE 1247360 0 0 OSI PHARMACEUTICALS INC COM 671040103 27338896 554654 SH SOLE 554654 0 0 OSIRIS THERAPEUTICS INC COM 68827R108 85107 4412 SH SOLE 4412 0 0 QUEST DIAGNOSTICS INC COM 74834L100 6122895 118500 SH SOLE 118500 0 0 QUIDEL CORP COM 74838J101 40894557 2492051 SH SOLE 2492051 0 0 SEPRACOR INC COM 817315104 2762833 150892 SH SOLE 150892 0 0 TENET HEALTHCARE CORP COM 88033G100 59061352 10641685 SH SOLE 10641685 0 0 TRANSITION THERAPEUTICS INC COM NEW 893716209 11615378 1677926 SH SOLE 1677926 0 0 UNITED THERAPEUTICS CORP DEL COM 91307C102 42087667 400187 SH SOLE 400187 0 0 VCA ANTECH INC COM 918194101 14660883 497485 SH SOLE 497485 0 0 WEBMD HEALTH CORP CL A 94770V102 6461699 217273 SH SOLE 217273 0 0
-----END PRIVACY-ENHANCED MESSAGE-----